Italy· 020601098
LINCOCIN*1 flaconcino iniett 600 mg 2 ml
A lincomycin product containing lincomicina, registered in Italy by PFIZER ITALIA Srl, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Lincomycin is registered in 5 of 19 countries.
Countries holding a registration under ATC J01FF02 (lincomycin), each read from that country’s own register.
- This record: Italy
- 4 of them publish a price we can compare per daily dose
Lincomycin · ATC J01FF02
5 / 19 countries
- Belgiumprice
- Italyprice
- Japan
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of lincomycin costs, country by country.
Normalised to the WHO defined daily dose (1.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lincomycin · price per daily dose (1.8 g)
USD · FX 28 Sept 2026
- ES Spain$3.09
The record
At a glance
- Active substance
- Lincomicina
- Manufacturer
- PFIZER ITALIA Srl
- Country
- Italy (IT)
- ATC code
- J01FF02
- ATC class
- Lincomycin
- Defined daily dose
- 1.8 g, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic020601098LINCOCIN*1 flaconcino iniett 600 mg 2 mlEUR 2.38
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
31 interactions on record for lincomycin.
Graded by severity as the source publishes them — 11 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lincomycin · interactions on record
31 records
- 11 moderate
- 20 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- KaolinA07BC02moderate
- AttapulgiteA07BC04moderate
- BalsalazideA07EC04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lincomycin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLincocinPharmacia & Upjohn Company LLC
- CanadaLINCOMED 100BIMEDA-MTC ANIMAL HEALTH INC
- BelgiumLincocin 250 mg/5 mlPfizer
- FinlandLincocin vetZoetis Animal Health ApS
- PolandLincocinDelfarma Sp. z o.o.
- SpainLINCOCIN 500 MG CAPSULAS DURASPfizer S.L.
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Lincocin
- Bulgaria · Линкомицин Абр
- Cyprus · Comycin, Lincomed
- Spain · Lincocin
- Greece · Pecasolin
- Lithuania · Lincocin
- Luxembourg · Lincocin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a123ee2-ebea-4535-978d-62164ebc0da3 GET /v1/drugs/4a123ee2-ebea-4535-978d-62164ebc0da3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 2.38,
"source": "aifa",
"currency": "EUR",
"strength": "LINCOMICINA 600MG 1 UNITA' USO PARENTERALE",
"substance": "Lincomicina",
"equivalence_group": "O2B",
"transparency_flag": null
}See everything about lincomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.